Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announces that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia (CLTI). Under the terms of the agreement, Inari will pay $250 million in cash at closing and LimFlow will be eligible to receive additional cash payments based on certain commercial and reimbursement milestones.

Read the full article: Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow //

Source: https://www.globenewswire.com/news-release/2023/11/01/2771666/0/en/Inari-Medical-Expands-Its-Patient-Focused-Mission-with-Agreement-to-Acquire-LimFlow.html

Scroll to Top